These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 20363305)
1. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG). Chandran T; Katragadda U; Teng Q; Tan C Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305 [TBL] [Abstract][Full Text] [Related]
2. Multi-drug delivery to tumor cells via micellar nanocarriers. Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Li F; Danquah M; Mahato RI Biomacromolecules; 2010 Oct; 11(10):2610-20. PubMed ID: 20804201 [TBL] [Abstract][Full Text] [Related]
5. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration. Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821 [TBL] [Abstract][Full Text] [Related]
6. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids. Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical. Shen R; Kim JJ; Yao M; Elbayoumi TA Int J Nanomedicine; 2016; 11():1687-700. PubMed ID: 27217747 [TBL] [Abstract][Full Text] [Related]
8. Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS. Yan H; Wei P; Song J; Jia X; Zhang Z J Pharm Pharmacol; 2016 Oct; 68(10):1290-8. PubMed ID: 27465923 [TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme. Saxena V; Hussain MD Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704 [TBL] [Abstract][Full Text] [Related]
10. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059 [TBL] [Abstract][Full Text] [Related]
11. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro. Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923 [TBL] [Abstract][Full Text] [Related]
12. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Zhang Z; Feng SS Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085 [TBL] [Abstract][Full Text] [Related]
13. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Sezgin Z; Yuksel N; Baykara T Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200 [TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
15. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Mu L; Elbayoumi TA; Torchilin VP Int J Pharm; 2005 Dec; 306(1-2):142-9. PubMed ID: 16242875 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Sezgin Z; Yüksel N; Baykara T Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896 [TBL] [Abstract][Full Text] [Related]
17. New self-assembling polyaspartylhydrazide copolymer micelles for anticancer drug delivery. Licciardi M; Cavallaro G; Di Stefano M; Pitarresi G; Fiorica C; Giammona G Int J Pharm; 2010 Aug; 396(1-2):219-28. PubMed ID: 20600731 [TBL] [Abstract][Full Text] [Related]
18. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation. Zheng C; Qiu L; Yao X; Zhu K Int J Pharm; 2009 May; 373(1-2):133-40. PubMed ID: 19429298 [TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Dabholkar RD; Sawant RM; Mongayt DA; Devarajan PV; Torchilin VP Int J Pharm; 2006 Jun; 315(1-2):148-57. PubMed ID: 16616818 [TBL] [Abstract][Full Text] [Related]
20. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats. Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]